The late open artery hypothesis--a decade later.
暂无分享,去创建一个
G. Lamas | C. Buller | J. Hochman | V. Džavík | V. Menon | M. Terrin | V. Menon | S. Sadanandan | B. Thompson
[1] David O. Williams,et al. ACC/AHA Guidelines for Percutaneous Coronary Intervention (Revision of the 1993 PTCA Guidelines)—Executive Summary , 2001 .
[2] H. Figulla,et al. Immediate Changes of Collateral Function After Successful Recanalization of Chronic Total Coronary Occlusions , 2000, Circulation.
[3] J. Hochman,et al. Relation between infarct artery patency at late angiography after acute myocardial infarction and signal-averaged electrocardiography. , 1999, The American journal of cardiology.
[4] V Hombach,et al. A randomized trial of elective stenting after balloon recanalization of chronic total occlusions. , 1999, Journal of the American College of Cardiology.
[5] K. Teo,et al. Primary stenting versus balloon angioplasty in occluded coronary arteries: the Total Occlusion Study of Canada (TOSCA). , 1999, Circulation.
[6] R. Sciacca,et al. New-onset sustained ventricular tachycardia after cardiac surgery. , 1999, Circulation.
[7] R. Califf,et al. Support for the open-artery hypothesis in survivors of acute myocardial infarction: analysis of 11,228 patients treated with thrombolytic therapy. , 1999, The American journal of cardiology.
[8] M. Kinoshita,et al. Long-term beneficial effect of late reperfusion for acute anterior myocardial infarction with percutaneous transluminal coronary angioplasty. , 1998, Circulation.
[9] T. Investigators. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. , 1998, Lancet.
[10] E. Topol. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade , 1998, The Lancet.
[11] C. Vassanelli,et al. Stent implantation versus balloon angioplasty in chronic coronary occlusions: results from the GISSOC trial. Gruppo Italiano di Studio sullo Stent nelle Occlusioni Coronariche. , 1998, Journal of the American College of Cardiology.
[12] Yuan Zhang,et al. Use of reperfusion therapy for acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2. , 1998, Circulation.
[13] H. White. Should all occluded infarct-related arteries be opened? , 1997, European heart journal.
[14] M. Simoons,et al. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. , 1997, The New England journal of medicine.
[15] Epilog Investigators,et al. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. , 1997, The New England journal of medicine.
[16] J. J. Griffin,et al. A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. Second Primary Angioplasty in Myocardial Infarction (PAMI-II) Trial Investigators. , 1997, Journal of the American College of Cardiology.
[17] M. Verani,et al. Association of angiotensin I-converting enzyme gene polymorphism with myocardial ischemia and patency of infarct-related artery in patients with acute myocardial infarction. , 1997, Journal of the American College of Cardiology.
[18] K. Endresen,et al. Stenting in Chronic Coronary Occlusion (SICCO): a randomized, controlled trial of adding stent implantation after successful angioplasty. , 1996, Journal of the American College of Cardiology.
[19] R. Califf,et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). , 1996, Journal of the American College of Cardiology.
[20] Richard P. Lewis,et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). , 1996, Journal of the American College of Cardiology.
[21] T. Hayashi,et al. Comparison of results of intracoronary implantation of the Plamaz-Schatz stent with conventional balloon angioplasty in chronic total coronary arterial occlusion. , 1996, The American journal of cardiology.
[22] S. Chierchia,et al. Coronary recanalization by elective angioplasty prevents ventricular dilation after anterior myocardial infarction. , 1996, Journal of the American College of Cardiology.
[23] J. Hochman. Has the time come to seek and open all occluded infarct-related arteries after myocardial infarction? , 1996, Journal of the American College of Cardiology.
[24] W. Weaver,et al. Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RAPID II Investigators. , 1996, Circulation.
[25] B. Brodie,et al. Importance of infarct-related artery patency for recovery of left ventricular function and late survival after primary angioplasty for acute myocardial infarction. , 1996, Journal of the American College of Cardiology.
[26] J. Muller,et al. A patent infarct-related artery is associated with reduced long-term mortality after percutaneous transluminal coronary angioplasty for postinfarction ischemia and an ejection fraction <50%. , 1996, Circulation.
[27] S. Pocock,et al. Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery , 1995, The Lancet.
[28] G. Lamas,et al. Effect of infarct artery patency on prognosis after acute myocardial infarction. The Survival and Ventricular Enlargement Investigators. , 1995, Circulation.
[29] R. Califf,et al. Percutaneous revascularization of chronic coronary occlusions: an overview. , 1995, Journal of the American College of Cardiology.
[30] S. Kimber,et al. Does late revascularization alter the evolution of the signal-averaged electrocardiogram in patients with a recent transmural myocardial infarction? , 1995, The Canadian journal of cardiology.
[31] C. Werter,et al. Left ventricular function at 3 months after successful thrombolysis. Impact of reocclusion without reinfarction on ejection fraction, regional function, and remodeling. , 1994, Circulation.
[32] T. Chalmers,et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration , 1994, The Lancet.
[33] E. Topol,et al. Effects of Thrombolytic Therapy Administered 6 to 24 Hours After Myocardial Infarction on the Signal‐Averaged ECG: Results of a Multicenter Randomized Trial , 1994, Circulation.
[34] R F Davies,et al. Effects of late percutaneous transluminal coronary angioplasty of an occluded infarct-related coronary artery on left ventricular function in patients with a recent (< 6 weeks) Q-wave acute myocardial infarction (Total Occlusion Post-Myocardial Infarction Intervention Study [TOMIIS]--a pilot study). , 1994, The American journal of cardiology.
[35] Epic Investigators,et al. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. , 1994, The New England journal of medicine.
[36] Gusto Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. , 1993, The New England journal of medicine.
[37] E. Braunwald,et al. Potential benefits of late reperfusion of infarcted myocardium. The open artery hypothesis. , 1993, Circulation.
[38] E. Boerwinkle,et al. Relation of plasma lipoprotein(a) to infarct artery patency in survivors of myocardial infarction. , 1993, Circulation.
[39] J O'Keefe,et al. A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction , 1993 .
[40] S. Kaul,et al. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. , 1992, The New England journal of medicine.
[41] P. Grayburn,et al. Effect of coronary angioplasty on late potentials one to two weeks after acute myocardial infarction. , 1992, The American journal of cardiology.
[42] C. Lau,et al. Effects of severity of the residual stenosis of the infarct-related coronary artery on left ventricular dilation and function after acute myocardial infarction. , 1992, Journal of the American College of Cardiology.
[43] Eric J. Topol,et al. A Randomized Trial of Late Reperfusion Therapy for Acute Myocardial Infarction , 1992, Circulation.
[44] L. Hillis,et al. Time for a prospective, randomized trial of the "open artery hypothesis" in survivors of acute myocardial infarction. , 1992, The American journal of cardiology.
[45] P. Hartigan,et al. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators. , 1992, The New England journal of medicine.
[46] H. Gohlke,et al. Prognostic importance of collateral flow and residual coronary stenosis of the myocardial infarct artery after anterior wall Q-wave acute myocardial infarction. , 1991, The American journal of cardiology.
[47] R. Califf,et al. From myocardial salvage to patient salvage in acute myocardial infarction: the role of reperfusion therapy. , 1989, Journal of the American College of Cardiology.
[48] E. Kim,et al. Coronary Arteriography in Acute Transmural Myocardial Infarction , 1989 .
[49] L. Hillis,et al. Prognosis after acute myocardial infarction in patients with and without residual anterograde coronary blood flow. , 1989, The American journal of cardiology.
[50] F. Werf. DISCREPANCIES BETWEEN THE EFFECTS OF CORONARY REPERFUSION ON SURVIVAL AND LEFT VENTRICULAR FUNCTION , 1989, The Lancet.
[51] E. Braunwald,et al. Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded? , 1989, Circulation.
[52] F. Sheehan,et al. Early recovery of left ventricular function after thrombolytic therapy for acute myocardial infarction: an important determinant of survival. , 1988, Journal of the American College of Cardiology.
[53] P. Sager,et al. Electrophysiologic effects of thrombolytic therapy in patients with a transmural anterior myocardial infarction complicated by left ventricular aneurysm formation. , 1988, Journal of the American College of Cardiology.
[54] H. White,et al. Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction. , 1987, The New England journal of medicine.
[55] R M Whitlock,et al. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. , 1987, Circulation.
[56] R. Jeremy,et al. Infarct artery perfusion and changes in left ventricular volume in the month after acute myocardial infarction. , 1987, Journal of the American College of Cardiology.
[57] W. Stevenson,et al. Effects of early reperfusion in acute myocardial infarction on arrhythmias induced by programmed stimulation: a prospective, randomized study. , 1986, Journal of the American College of Cardiology.
[58] H. Stein,et al. Tumor of the heart diagnosed by magnetic resonance imaging. , 1985, Journal of the American College of Cardiology.
[59] J. Ritchie,et al. Global and regional left ventricular function and tomographic radionuclide perfusion: the Western Washington Intracoronary Streptokinase In Myocardial Infarction Trial. , 1984, Circulation.
[60] G. Sanz,et al. Angiographic Findings 1 Month After Myocardial Infarction: A Prospective Study of 259 Survivors , 1982, Circulation.
[61] M S Golden,et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. , 1980, The New England journal of medicine.
[62] J. Lowe,et al. The Wavefront Phenomenon of Ischemic Cell Death: 1. Myocardial Infarct Size vs Duration of Coronary Occlusion in Dogs , 1977, Circulation.
[63] C. Leman. The Veterans Administration. , 1970, Lancet.
[64] H. White,et al. Long-term prognostic importance of patency of the infarct-related coronary artery after thrombolytic therapy for acute myocardial infarction. , 1994, Circulation.
[65] Johan Herlitz,et al. Indications for fibrinolytic therapy in suspected acute myocardial infarction : collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients , 1994 .
[66] M. Galvani,et al. Patency of the infarct-related artery and left ventricular function as the major determinants of survival after Q-wave acute myocardial infarction. , 1993, The American journal of cardiology.
[67] R. Califf,et al. Long-term survival from acute myocardial infarction: salutary effect of an open coronary vessel. , 1990, The American journal of medicine.
[68] J. Hochman,et al. Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage. , 1987, Circulation.